MAGNESIUM LACTATE

Details

Stereochemistry	RACEMIC
Molecular Formula	2C3H5O3.Mg
Molecular Weight	202.445
Optical Activity	( + / - )
Defined Stereocenters	0 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

[Mg++].CC(O)C([O-])=O.CC(O)C([O-])=O

InChI

InChIKey=OVGXLJDWSLQDRT-UHFFFAOYSA-L

InChI=1S/2C3H6O3.Mg/c2*1-2(4)3(5)6;/h2*2,4H,1H3,(H,5,6);/q;;+2/p-2

HIDE SMILES / InChI

Molecular Formula	C3H5O3
Molecular Weight	89.07
Charge	-1
Count	MOL RATIO 2 MOL RATIO (average)

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Molecular Formula	Mg
Molecular Weight	24.305
Charge	2
Count	MOL RATIO 1 MOL RATIO (average)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description

Struvite, a crystalline substance first identified in the 18th century, is composed of magnesium ammonium phosphate. Struvite urinary stones are also known as ‘infection stones’, and account for 15%-20% of all urinary stones. Bacterial urease, usually from a Proteus species, is responsible for the chemical changes in urine which result in struvite formation.

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
action potential 66	Inhibitor 8,297
magnesium ion homeostasis 70	Modulator 828
magnesium ion homeostasis 70	Modulator 828
oxalate metabolic process 66	Modulator 828
magnesium ion homeostasis 70	Modulator 828
magnesium ion homeostasis 70	Interacts 323
Protein S100-A8 66	Binding Agent 1,064

Conditions

Condition	Modality	Highest Phase	Product
Unknown 2,578
Unknown 2,578
Bone disease 70	Primary	Basic research	Unknown
Bacterial infections 234	Primary	Preclinical	Unknown
Bronchial spasm 78	Primary	Preclinical	Unknown
Unknown 2,578
Unknown 2,578
Unknown 2,578
Preeclampsia 85	Preventing	Approved 8,429	MAGNESIUM SULFATE
Eclampsia 69	Primary	Approved 8,429	MAGNESIUM SULFATE
Preparation for colonoscopy 66	Diagnostic	Approved 8,429	ColPrep Kit
Atrial fibrillation 131	Primary	Phase III 656	MAGNESIUM SULFATE
Unknown 2,578
Magnesium deficiency 67	Curative	Approved 8,429	MagMin
Unknown 2,578
Magnesium deficiency 67	Curative	Not Provided 504	DELBIASE
Eclampsia 69	Primary	Not Provided 504	DELBIASE
Convulsions 72	Primary	Not Provided 504	DELBIASE
Magnesium deficiency 67	Curative	Approved 8,429	Magnesium Chloride
Fibromyalgia 89	Palliative	Phase II 1,132	Magnesium Chloride
Stroke 144	Palliative	Phase III 656	Magnesium Chloride
Oxaluria 66	Primary	Approved 8,429	EPIMAG
Constipation 112	Primary	Approved 8,429	EPIMAG
Magnesium deficiency 67	Curative	Approved 8,429	Magnesium Citrate
Unknown 2,578
Magnesium deficiency 67	Curative	Approved 8,429	Unknown

PubMed

Show entries

Title	Date	PubMed
Evidence for separate peptide sequences related to the lipolytic and magnesium-accumulating activities of ACTH. Analogy with adrenergic receptors.	1977 Apr	191614
Serum calcium and magnesium levels in schizophrenia. II. Possible relationship to extrapyramidal symptoms.	1979 Nov	496555
Fluorimetry of selenium in body fluids after digestion with nitric acid, magnesium nitrate hexahydrate, and hydrochloric acid.	1988 Sep	2843308
Effect of magnesium diet in gentamicin-induced acute renal failure in rats.	1989	2915758
[Heart rate disorders in potassium and magnesium deficiency].	1992 Sep 7	1413169

Showing 1 to 5 of 50 entries

Previous1 2 3 4 5…10Next

Patents

Sample Use Guides

In Vivo Use Guide

Murine osteomyelitis model: medical pure titanium plates in size of 10 mm × 10 mm × 1 mm were used for the deposition of Magnesium Fluoride (MgF2) film.

Route of Administration: Topical

In Vitro Use Guide

Unknown